Turning Point Therapeutics, Inc. Earnings Per Share (Diluted)
Turning Point Therapeutics, Inc. reported Earnings Per Share (Diluted) of -$2.48 per share for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2022-08-08
- Turning Point Therapeutics, Inc. earnings per share, diluted for the quarter ending 2022-06-30 was -$2.48.
- Turning Point Therapeutics, Inc. earnings per share, diluted for the quarter ending 2021-06-30 was -$1.14.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month |
|---|---|---|
| 2022-06-30 | -$2.48 10-Q · filed 2022-08-08 | -$3.98 10-Q · filed 2022-08-08 |
| 2021-06-30 | -$1.14 10-Q · filed 2022-08-08 | -$1.87 10-Q · filed 2022-08-08 |